Nu-Med Plus (NUMD) Enterprise Value Growth (3y) (2014 - 2025)
Nu-Med Plus (NUMD) Enterprise Value Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 79.18% |
| Sep 30, 2025 | -45.84% |
| Mar 31, 2025 | 2.20% |
| Dec 31, 2024 | 41.20% |
| Sep 30, 2024 | 49.75% |
| Jun 30, 2024 | 61.86% |
| Mar 31, 2024 | 64.26% |
| Dec 31, 2023 | 66.95% |
| Sep 30, 2023 | 29.39% |
| Jun 30, 2023 | -69.92% |
| Mar 31, 2023 | -42.49% |
| Dec 31, 2022 | -117.86% |
| Sep 30, 2022 | 75.33% |
| Mar 31, 2022 | 52.23% |
| Dec 31, 2021 | 58.85% |
| Sep 30, 2021 | 42.59% |
| Jun 30, 2021 | 36.79% |
| Mar 31, 2021 | 20.33% |
| Dec 31, 2020 | 18.72% |
| Sep 30, 2020 | 57.47% |